Ingevity (NGVT) was Initiated by Aegis Capital to “Buy”. Aegis Capital advised their investors in a research report released on Nov 22, 2016.
Many Wall Street Analysts have commented on Ingevity. Ingevity was Initiated by Buckingham Research to “Neutral” on Sep 23, 2016. Ingevity was Initiated by Jefferies to “Buy” on Sep 23, 2016.
On the company’s financial health, Ingevity reported $0.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Nov 2, 2016. Analyst had a consensus of $0.61. The company had revenue of $252.00 million for the quarter, compared to analysts expectations of $241.78 million. The company’s revenue was down -1.8 % compared to the same quarter last year.